A Phase II Trial of PS-341 in Combination With Paclitaxel and Carboplatin for Metastatic Adenocarcinoma of the Lower Esophagus, Gastroesophageal Junction, and Gastric Cardia.
Phase of Trial: Phase II
Latest Information Update: 15 Dec 2016
At a glance
- Drugs Bortezomib (Primary) ; Carboplatin; Paclitaxel
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 13 May 2008 Status changed from in progress to completed, reported by ClinicalTrials.gov.
- 15 Aug 2005 New trial record.